Erratum to: Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury
- 46 Downloads
The following paragraph was published in: Christoph Ott, Henrik Martens, Imam Hassouna, Bárbara Oliveira, Christian Erck, Maria-Patapia Zafeiriou, Ulla-Kaisa Peteri, Dörte Hesse, Simone Gerhart, Bekir Altas, Tekla Kolbow, Herbert Stadler, Hiroshi Kawabe, Wolfram-Hubertus Zimmermann, Klaus-Armin Nave, Walter Schulz-Schaeffer, Olaf Jahn, and Hannelore Ehrenreich. Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury. Mol. Med. 21:803-15.
Antibodies against EPOR (EPOR-AB) have been widely used to characterize EPOR expression and localization, but cell surface EPOR expression is low, even in stimulated states, and, most importantly, all commercially available EPOR-AB have been hampered by nonspecific cross-reactivities, calling into question the literature based exclusively on them. This, in turn, raised discussions within the scientific community, questioning the expression of EPOR in extra-hematopoietic tissues (14–16). These discussions were likely nurtured by conflicts of interest, trying to restrict the effects of EPO, a highly attractive compound commercially for the anemia market, to hematopoiesis. Nevertheless, they made it very obvious that the existing EPOR-AB were essentially unreliable, and that the production and thorough characterization of new and more specific EPOR-AB had to be seen as a major challenge for the future (14,17–18).
Molecular Medicine encourages scientific discourse, but does not impute motive in disagreements. The editors apologize for this oversight.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.
The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)